From Our Partners
Saturday, June 25, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biodetection

Notable Contracts: Meso Scale Diagnostics

by Global Biodefense Staff
June 30, 2014

The United States Army Medical Research Acquisition Activity (USAMRAA), Fort Detrick, MD recently announced intentions to issue a sole source award to Meso Scale Diagnostics, LLC for multiple MSD PR2 Model 1800 instruments and corresponding service packages.

The acquisition is on behalf of the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID). The Field Identification of Biological Warfare Agents (FIBWA) program conducted by USAMRIID provides advanced biological warfare detection training to 52 National Guard Weapons of Mass Destruction Civil Support Teams (WMD-CST) across the U.S and its territories. The CSTs have recently transitioned to the MSD PR2 platform and USAMRIID requires the instruments in order to provide the CSTs with relevant training.

“Successful training of the CSTs and the implementation of the FIBWA program cannot be completed unless USAMRIID has the exact same platform as the CSTs,” states the announcement.

The PR2 Model 1800 has the following characteristics listed as essential to the requirements at USAMRIID: ability to measure multiple agents (toxins, viruses and bacteria) from a single sample, electrochemiluminescence (ECL) signal detection technology, plate based immunoassay system capable of 96-well (9, 16, and 25 spot multiplex plates), detection electronics – cooled CCD camera, plate read time – 7 minutes, dynamic assay range of 10^5 over the spectrum of assays, temperature operational range 15-30 C minimum, and a system foot print of less than 18 x 18 inches.

Source: FBO.gov

From Our Partners
Tags: Mobile ResponseUSAMRIID

Related Posts

Influenza Research
Biodetection

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022
Biodefense Industry News
Industry News

Tonix Pharmaceuticals Opens Advanced Development Center for Vaccine Programs

June 20, 2022
Novavax Missed Its Global Moonshot but Is Angling to Win Over mRNA Defectors
Industry News

Novavax Missed Its Global Moonshot but Is Angling to Win Over mRNA Defectors

May 26, 2022
NIH to Further Invest in Point-of-Care Technologies Research Network
Biodetection

NIH to Further Invest in Point-of-Care Technologies Research Network

May 10, 2022
Load More

Latest News

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

June 22, 2022
Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

June 22, 2022
UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Influenza Research

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC